Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. lifted its holdings in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 0.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 466,706 shares of the company’s stock after buying an additional 4,047 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Aveanna Healthcare were worth $2,133,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of AVAH. Rhumbline Advisers boosted its stake in Aveanna Healthcare by 11.1% during the 4th quarter. Rhumbline Advisers now owns 72,663 shares of the company’s stock valued at $332,000 after acquiring an additional 7,257 shares during the last quarter. Legato Capital Management LLC acquired a new stake in Aveanna Healthcare in the fourth quarter worth about $83,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in Aveanna Healthcare by 15.7% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 25,171 shares of the company’s stock worth $115,000 after purchasing an additional 3,407 shares during the period. SG Americas Securities LLC grew its holdings in Aveanna Healthcare by 26.0% during the fourth quarter. SG Americas Securities LLC now owns 24,366 shares of the company’s stock worth $111,000 after acquiring an additional 5,031 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in shares of Aveanna Healthcare by 266.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company’s stock worth $446,000 after acquiring an additional 62,319 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on AVAH shares. Truist Financial reduced their price objective on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research note on Monday, January 6th. UBS Group increased their price objective on Aveanna Healthcare from $3.20 to $4.50 and gave the company a “sell” rating in a research report on Friday, March 14th.

Aveanna Healthcare Trading Down 2.7 %

Shares of AVAH opened at $5.37 on Friday. Aveanna Healthcare Holdings Inc. has a 1 year low of $2.11 and a 1 year high of $6.19. The stock has a 50 day simple moving average of $4.73 and a 200-day simple moving average of $4.96. The stock has a market cap of $1.05 billion, a PE ratio of -15.79 and a beta of 2.25.

Insider Buying and Selling

In other news, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total transaction of $339,217.64. Following the transaction, the insider now directly owns 1,453,948 shares in the company, valued at approximately $8,011,253.48. This represents a 4.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 7.80% of the stock is currently owned by corporate insiders.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.